97 related articles for article (PubMed ID: 6364320)
1. Studies of cellular immunity in Graves' disease.
Zosin I; Simionescu L; Arcan P; Lungu G
Endocrinologie; 1983; 21(4):267-72. PubMed ID: 6364320
[TBL] [Abstract][Full Text] [Related]
2. Increase of peripheral B lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
[TBL] [Abstract][Full Text] [Related]
3. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
4. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
5. Studies on T and B lymphocytes by the technique of immune and non-immune rosettes and by scanning electron microscopy (SEM) in Graves' disease and nontoxic nodular goiter.
Necula M
Endocrinologie; 1983; 21(4):261-5. PubMed ID: 6607508
[TBL] [Abstract][Full Text] [Related]
6. B- and T-lymphocytes in toxic diffuse goitre.
Sköldstam L; Anderberg B; Norrby K
Clin Exp Immunol; 1978 Mar; 31(3):524-5. PubMed ID: 350461
[TBL] [Abstract][Full Text] [Related]
7. Production of migration inhibitory factor in response to bacterial and fungal antigens in patients with untreated Graves' disease.
Wall JR; Ryan EA
Can Med Assoc J; 1980 Jun; 122(11):1264-9. PubMed ID: 6446374
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte migration inhibition in vitro in untreated and methimazole-treated patients with Graves disease.
Kálmán K; Fazakas S; Erdei I; Leövey A
Acta Med Acad Sci Hung; 1976; 33(4):327-32. PubMed ID: 1037636
[TBL] [Abstract][Full Text] [Related]
9. Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus.
Topliss D; How J; Lewis M; Row V; Volpé R
J Clin Endocrinol Metab; 1983 Oct; 57(4):700-5. PubMed ID: 6224805
[TBL] [Abstract][Full Text] [Related]
10. Some aspects of cellular and humoral immunity in bronchial asthma and allergic rhinitis.
Stanciu L; Urcan S; Părău N; Radu D; Itu I; Georoceanu A
Med Interne; 1983; 21(1):19-22. PubMed ID: 6342109
[TBL] [Abstract][Full Text] [Related]
11. Aspects concerning the lymphocytic nonimmune and immune rosettes in Graves' disease and thyroiditis.
Milcu SM; Necula M
Endocrinologie; 1978; 16(1):51-4. PubMed ID: 305607
[TBL] [Abstract][Full Text] [Related]
12. T-lymphocyte sensitization in Graves' and Hashimoto's diseases confirmed by an indirect migration inhibition factor test.
Okita N; Topliss D; Lewis M; Row VV; Volpé R
J Clin Endocrinol Metab; 1981 Mar; 52(3):523-7. PubMed ID: 7007410
[TBL] [Abstract][Full Text] [Related]
13. Activated lymphocytes in the peripheral blood in acute hyperthyroidism (Graves' disease).
Folb PI; Bank H
Isr J Med Sci; 1974 Jul; 10(7):785-7. PubMed ID: 4408149
[No Abstract] [Full Text] [Related]
14. Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen.
McLachlan SM; Dickinson AM; Malcolm A; Farndon JR; Young E; Proctor SJ; Smith BR
Clin Exp Immunol; 1983 Apr; 52(1):45-53. PubMed ID: 6602673
[TBL] [Abstract][Full Text] [Related]
15. [Effect of sera from patients with Graves' disease on the E-rosette function of normal lymphocytes].
Indiveri F; Franceschini R; Soldà AM; Barabino A
Boll Ist Sieroter Milan; 1977 Mar; 56(2):136-8. PubMed ID: 326271
[TBL] [Abstract][Full Text] [Related]
16. Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytes.
Okita N; How J; Topliss D; Lewis M; Row VV; Volpé R
J Clin Endocrinol Metab; 1981 Nov; 53(5):1002-7. PubMed ID: 7026590
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease: in situ localization of lymphoid T cell subpopulations.
Bene MC; Derennes V; Faure G; Thomas JL; Duheille J; Leclere J
Clin Exp Immunol; 1983 May; 52(2):311-6. PubMed ID: 6345038
[TBL] [Abstract][Full Text] [Related]
18. The alterations of CD11A expression on peripheral blood lymphocytes/monocytes and CD62L expression on peripheral blood lymphocytes in Graves' disease and type 1 diabetes.
Kretowski A; Myśliwiec J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():151-9. PubMed ID: 10697430
[TBL] [Abstract][Full Text] [Related]
19. Graves' ophthalmopathy--immunologic parameters related to corticosteroid therapy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ
Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):173-82. PubMed ID: 6970185
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of spontaneous E-rosetting by antithymocyte globulin in Graves disease.
Balázs C; Leövey A; Sztojka I; Szerze P; Szabó M; Bordán L; Fazakas S
Acta Med Acad Sci Hung; 1976; 33(4):333-8. PubMed ID: 1088590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
